119 related articles for article (PubMed ID: 8843076)
21. In vivo regulation of central nervous system progesterone receptors: cocaine induces steroid-dependent behavior through dopamine transporter modulation of D5 receptors in rats.
Apostolakis EM; Garai J; Clark JH; O'Malley BW
Mol Endocrinol; 1996 Dec; 10(12):1595-604. PubMed ID: 8961269
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo effects of cocaine and selected local anesthetics on the dopamine transporter.
Woodward JJ; Compton DM; Balster RL; Martin BR
Eur J Pharmacol; 1995 Apr; 277(1):7-13. PubMed ID: 7635175
[TBL] [Abstract][Full Text] [Related]
23. Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells.
Nishimura M; Sato K; Okada T; Yoshiya I; Schloss P; Shimada S; Tohyama M
Anesthesiology; 1998 Mar; 88(3):768-74. PubMed ID: 9523822
[TBL] [Abstract][Full Text] [Related]
24. Cloning and expression of a cocaine-sensitive rat dopamine transporter.
Kilty JE; Lorang D; Amara SG
Science; 1991 Oct; 254(5031):578-9. PubMed ID: 1948035
[TBL] [Abstract][Full Text] [Related]
25. Selective role of glutathione in protecting human neuronal cells from dopamine-induced apoptosis.
Gabby M; Tauber M; Porat S; Simantov R
Neuropharmacology; 1996 May; 35(5):571-8. PubMed ID: 8887964
[TBL] [Abstract][Full Text] [Related]
26. Antiproliferative action of dopamine and norepinephrine in neuroblastoma cells expressing the human dopamine transporter.
Pifl C; Zezula J; Spittler A; Kattinger A; Reither H; Caron MG; Hornykiewicz O
FASEB J; 2001 Jul; 15(9):1607-9. PubMed ID: 11427501
[No Abstract] [Full Text] [Related]
27. Temperature and 3,4-methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake.
Saldaña SN; Barker EL
Neurosci Lett; 2004 Jan; 354(3):209-12. PubMed ID: 14700733
[TBL] [Abstract][Full Text] [Related]
28. Drug interactions with the dopamine transporter in cryopreserved human caudate.
Eshleman AJ; Wolfrum K; Mash DC; Christensen K; Janowsky A
J Pharmacol Exp Ther; 2001 Feb; 296(2):442-9. PubMed ID: 11160629
[TBL] [Abstract][Full Text] [Related]
29. Pharmacology and regulation of the neuronal dopamine transporter.
Reith ME; Xu C; Chen NH
Eur J Pharmacol; 1997 Apr; 324(1):1-10. PubMed ID: 9137907
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a recombinant human dopamine transporter in multiple cell lines.
Eshleman AJ; Neve RL; Janowsky A; Neve KA
J Pharmacol Exp Ther; 1995 Jul; 274(1):276-83. PubMed ID: 7616409
[TBL] [Abstract][Full Text] [Related]
31. Cocaine inhibits NGF-induced PC12 cells differentiation through D(1)-type dopamine receptors.
Zachor DA; Moore JF; Brezausek C; Theibert A; Percy AK
Brain Res; 2000 Jun; 869(1-2):85-97. PubMed ID: 10865062
[TBL] [Abstract][Full Text] [Related]
32. Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra.
Paris I; Martinez-Alvarado P; Perez-Pastene C; Vieira MN; Olea-Azar C; Raisman-Vozari R; Cardenas S; Graumann R; Caviedes P; Segura-Aguilar J
J Neurochem; 2005 Mar; 92(5):1021-32. PubMed ID: 15715653
[TBL] [Abstract][Full Text] [Related]
33. Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters.
Kokoshka JM; Vaughan RA; Hanson GR; Fleckenstein AE
Eur J Pharmacol; 1998 Nov; 361(2-3):269-75. PubMed ID: 9865517
[TBL] [Abstract][Full Text] [Related]
34. Rat mesencephalic neuronal cells cultured for different periods as a model of dopamine transporter ontogenesis.
Valchár M; Hanbauer I
Mol Neurobiol; 1995; 11(1-3):111-9. PubMed ID: 8561956
[TBL] [Abstract][Full Text] [Related]
35. Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes.
Doolen S; Zahniser NR
J Pharmacol Exp Ther; 2001 Mar; 296(3):931-8. PubMed ID: 11181926
[TBL] [Abstract][Full Text] [Related]
36. Molecular cloning and functional expression of the mouse dopamine transporter.
Brüss M; Wieland A; Bönisch H
J Neural Transm (Vienna); 1999; 106(7-8):657-62. PubMed ID: 10907725
[TBL] [Abstract][Full Text] [Related]
37. Induction by low Na+ or Cl- of cocaine sensitive carrier-mediated efflux of amines from cells transfected with the cloned human catecholamine transporters.
Pifl C; Agneter E; Drobny H; Reither H; Singer EA
Br J Pharmacol; 1997 May; 121(2):205-12. PubMed ID: 9154329
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the human dopamine transporter heterologously expressed in BHK-21 cells.
Lenhard T; Marheineke K; Lingen B; Haase W; Hammermann R; Michel H; Reiländer H
Cell Mol Neurobiol; 1998 Jun; 18(3):347-60. PubMed ID: 9590564
[TBL] [Abstract][Full Text] [Related]
39. Transporter-mediated actions of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane.
Shimazu S; Tsunekawa H; Yoneda F; Katsuki H; Akaike A; Janowsky A
Eur J Pharmacol; 2003 Dec; 482(1-3):9-16. PubMed ID: 14659999
[TBL] [Abstract][Full Text] [Related]
40. Species differences in functions of dopamine transporter: paucity of MPP+ uptake and cocaine binding in bovine dopamine transporter.
Lee SH; Rhee J; Koh JK; Lee YS
Neurosci Lett; 1996 Aug; 214(2-3):199-201. PubMed ID: 8878118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
